Paper Report for: Zhao_2006_Clin.Chim.Acta_365_149
Reference
Title: The -250G-->A polymorphism in the human hepatic lipase gene promoter affects blood lipids in Chinese Zhao S, Xie X, Nie S Ref: Clinica Chimica Acta, 365:149, 2006 : PubMed
BACKGROUND: Human hepatic lipase (HL) is a glycoprotein that catalyzes the hydrolysis of triglycerides and phospholipids in all major classes of lipoproteins. We studied whether the hepatic lipase gene -250G(guanine)-->A(adenine) polymorphism affect blood lipids level and the coronary heart disease. METHODS: Two hundred and thirty subjects were included. Among them there were 122 patients with coronary heart disease and 108 subjects without coronary heart disease. Polymerase chain reaction-restricted fragments length polymorphism was used to determine HL genotype. RESULTS: The serum HDL-C level of HL-250A heterozygote (carriers of GA genotype) and homozygote (carriers of AA genotype) [(1.32+/-0.35) mmol/l] was significantly higher than wild type [carriers of GG genotype, (1.19+/-0.30) mmol/l, P<0.005]. This effect to blood lipids appears more evident in women (P<0.005). But the distribution of the 3 genotypes of HL-250 among the patients with coronary heart disease (GG54.1%, GA37.7%, AA8.2%) were similar with those of the control (GG54.6%, GA37.0%, AA8.4%, P>0.05). Both the male and the female had similar ratio for 3 HL genotypes. CONCLUSIONS: HL-250G-->A variation affects blood lipids profile and results in the increasing of the serum HDL-C level. This beneficial effect to blood lipids profile is more obviously seen in the female.
Zhao S, Xie X, Nie S (2006) The -250G-->A polymorphism in the human hepatic lipase gene promoter affects blood lipids in Chinese Clinica Chimica Acta365: 149-52
Zhao S, Xie X, Nie S (2006) Clinica Chimica Acta365: 149-52